Dr. Driehuys was a co-inventor of hyperpolarized gas MRI while completing his Doctorate in atomic Physics at Princeton University in the 1990’s. In 1996, Dr. Driehuys helped to start MITI, a company founded to commercialize hyperpolarized gas technology. In 1999, Dr. Driehuys became CEO of the company, managed its acquisition by Amersham Health and he remained with the company as Director of the Research Triangle Park Facility until 2003. In this senior management position he oversaw all hyperpolarized gas physics and applications research. He served on the Amersham global imaging management team, which was broadly responsible for the company’s diagnostic imaging research pipeline, spanning all modalities and disease areas. In 2004, Dr. Driehuys returned to academia where is now an Associate Professor of Radiology, Medical Physics, and Biomedical Engineering at Duke University. His research program has been focused on driving the clinical translation of hyperpolarized 129Xe MRI, and exploiting the unique properties of this atom for molecular imaging.
Dr. Driehuys completed his post-doctoral work and Ph.D. in atomic physics at Princeton University after receiving his BA summa cum laude in physics from Franklin & Marshall College in Lancaster, PA. He has authored more than 50 publications in the areas of hyperpolarization physics and biological applications. He holds 32 granted US patents and is a co-recipient of the Thomas Alva Edison Patent Award, as well as the Tibbetts Award for Outstanding small business scientific accomplishment.
Mr. West’s began his career with Fortune 200 FMC Corporation in the 1980’s, where he was Director of Marketing and Business Development for a division that supplied excipient products to the pharmaceutical industry. Since that time, Mr. West has been involved at a senior level with 5 successful new companies in the medical technology field. He held senior management positions at three venture-capital backed start-ups, including Vice President of Sales, Marketing and Business Development at Embrex, Inc. a drug delivery company that went public and then was acquired by Pfizer; COO at VetInsite, a health care information technology company that was acquired by MediMedia; and Biolex, a transgenic protein company, where he was a founder and the first President/ COO. The company raised more than $180 million in venture capital and was acquired by Synthon. Mr. West has also led the US subsidiaries of two European medical device companies as they entered the US market, including Curasan AG and Tem International. As President of each of these US companies, Mr. West built and managed the US organizations, growing them into multi-million dollar subsidiaries with direct sales forces to physician offices and hospitals.
Mr. West holds a B.S. degree in chemical engineering from Cornell University and an MBA from the Wharton School of the University of Pennsylvania.
For the past ten years, Dr. Emami has been both a user and developer of HP gas technology and a leader of a number of HP gas projects at the Radiology Department of the University of Pennsylvania, a leading center for HP gas MRI. These projects have included a project to develop a multi-breath ventilation imaging protocol to measure specific ventilation distribution in lungs, and a passive HP gas delivery device, which enables metered administration consecutive HP gas breaths to conscious human subjects (patent pending).
While at the University of Pennsylvania, Dr. Emami was a Fellow of the University’s technology transfer center and Dr. Emami was also a co-founder of Spinhance, LLC, a company that designed and built the first fully automated 3He polarizer system to support a multi-site COPD ancillary study to be funded by NIH. Since joining Polarean in 2012, he has directed all aspects of Polarean’s technical efforts, including building, upgrading, installing, training and servicing 129Xe hyperpolarization systems around the world.
Dr. Emami holds a BS in mechanical engineering from KNT University of Technology (Tehran), an MS in bioengineering and a PhD in electrical and systems engineering; both form University of Pennsylvania.
Mr. Deaton is a veteran of product development serving in key roles with several successful high growth and entrepreneurial companies. His career includes product design and development from the start up of Magnetic Imaging Technologies Incorporated - precursor to Polarean. He later lead the inhalation device development group for publicly traded Kos Pharmaceuticals (acquired by Abbott in 2006). Dan was then Director of Product Development for Oriel Therapeutics, a venture backed respiratory pharmaceutical company spun out of UNC Chapel Hill. At Oriel, Dan lead a diverse a team of consultants and engineers that developed the Solis™ dry powder inhaler platform. In 2010 Oriel was acquired by Sandoz, the generic division of Novartis.
Dan has an MBA from the University of North Carolina at Chapel Hill as well as Bachelors and Masters of Science in Mechanical Engineering from North Carolina State University. He advises numerous early stage medical device and pharmaceutical companies and non-profits and is an active angel capital investor.
Mr. Sudol is a hands-on executive with over 25 years of operations experience with both FORTUNE 500 and small, private companies. He has evaluated business practices in over 100 companies in the US, Latin America, and the Far East and has consistently applied a blend of creative, operational and organizational strengths to achieve significant business improvements. He has been part of management teams that have acquired or sold 9 manufacturing and service companies.
Currently, Mr. Sudol is the Chief Operating Officer at Princeton Power Systems, a high-tech company that produces high performance power electronics, leading an objective to quadruple production output within a year with process improvements, strategic vendor relationships, product development and organizational improvement. Previously, Mr. Sudol cofounded Polarean Inc. in 2011 and served as its first President.
Mr. Sudol’s skills were well honed in both field and staff management roles at GE where he received intense training in world-class manufacturing and quality practices through GE’s 24-month Manufacturing Management Program. His educational foundation includes BS and MS degrees in Mechanical Engineering from Bucknell University and an MBA in Entrepreneurial Management from the Wharton School.